Equity Brief · Healthcare2026-05-20
RMD·Healthcare

ResMed Inc

I · Analyse IA

En bref

ResMed manufactures devices that help people breathe better during sleep—primarily CPAP machines and other equipment for sleep apnea—and also sells cloud-based software that home health agencies, nursing homes, and medical equipment suppliers use to manage patient records and billing [Yahoo Finance]. They operate in two main segments: Sleep and Breathing Health (the devices) and Residential Care Software (the healthcare management systems).

ResMed is a $30.1 billion medical device company that makes equipment to treat sleep apnea and other breathing disorders, along with software for home healthcare providers [Yahoo Finance]. The company just announced a partnership with Oura, a wearable ring maker, to screen for sleep problems earlier and expand its customer base beyond traditional doctor referrals [Simply Wall St]. Financially, ResMed is exceptionally strong with 27% profit margins, $1.7 billion in free cash flow, and a perfect 10/10 health score [Yahoo Finance].

ResMed is in outstanding financial shape with strong profitability, excellent cash generation, and essentially no net debt.

En bref AI analysisConfiance 8/10

Score Sentinellis

10/10

Financially healthy

Capitalisation boursière

$30.1B

Chiffre d'affaires (12 mois)

$5.1B

II · Actualités récentes

Ce qui a fait bouger le cours

3 stories · ranked by relevance

  • macro2026-05-20

    ResMed (RMD) Valuation Check As Oura Sleep Health Collaboration Aims To Expand Sleep Apnea Care Access

    Simply Wall St

  • macro2026-05-19

    Resmed Announces Participation in the 46th Annual William Blair Growth Stock Conference

    Yahoo Finance

  • macro2026-05-19

    Resmed and ŌURA Partner to Expand Access to Sleep Health Education and Care

    Yahoo Finance

Premium · gratuit avec tout compte

The stock has declined nearly 20% over the past three months despite strong fundamentals, indicating investors may be concerned about growth sustainability or competitive pressures not yet visible in the financial data [Simply Wall St].

1 sur 4 risques dans ce rapport

Risques

4

Opportunités

4

Signaux d'alerte

1

Direction

10

18 autres constats dans le rapport complet — gratuit avec tout compte.

Débloquer l'analyse complète de ResMed Inc

Créez un compte gratuit pour accéder au rapport complet généré par IA, avec les sources citées dans le texte.

  • 4 risques, 4 opportunités et 1 signal d'alerte — chacun avec sa source
  • Plus de 100 indicateurs financiers avec graphiques et comparaisons
  • Résumés d'actualités complets avec liens vers les sources
  • Équipe dirigeante et rémunération
  • Export PDF pour la lecture hors ligne
Débloquer les 9 constats3 rapports gratuits · sans carte

III · Entreprises similaires

À lire également

Same sector · Healthcare or comparable health

L'ajouter à votre liste ?

Read three companies free. Sans carte.

Obtenir 3 rapports gratuits